Pathogenic variants in arteriopathy genes detected in a targeted sequencing study: Penetrance and 1-year outcomes after return of results

Published:August 09, 2022DOI:



      We estimated the penetrance of pathogenic/likely pathogenic (P/LP) variants in arteriopathy-related genes and assessed near-term outcomes following return of results.


      Participants (N = 24,520) in phase III of the Electronic Medical Records and Genomics network underwent targeted sequencing of 68 actionable genes, including 9 genes associated with arterial aneurysmal diseases. Penetrance was estimated on the basis of the presence of relevant clinical traits. Outcomes occurring within 1 year of return of results included new diagnoses, referral to a specialist, new tests ordered, surveillance initiated, and new medications started.


      P/LP variants were present in 34 participants. The average penetrance across genes was 59%, ranging from 86% for FBN1 variants to 25% for SMAD3. Of 16 participants in whom results were returned, 1-year outcomes occurred in 63%. A new diagnosis was made in 44% of the participants, 56% were referred to a specialist, a new test was ordered in 44%, surveillance was initiated in 31%, and a new medication was started in 31%.


      Penetrance of P/LP variants in arteriopathy-related genes, identified in a large, targeted sequencing study, was variable and overall lower than that reported in clinical cohorts. Meaningful outcomes within the first year were noted in 63% of participants who received results.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      ACMG Member Login

      Are you an ACMG Member? Sign in for online access.


      Subscribe to Genetics in Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Richards S.
        • Aziz N.
        • Bale S.
        • et al.
        Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
        Genet Med. 2015; 17: 405-424
        • Miller D.T.
        • Lee K.
        • Gordon A.S.
        • et al.
        Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
        Genet Med. 2021; 23: 1391-1398
      1. Kalia SS, Adelman K, Bale SJ et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19(2):249-255. Published corrections appears in Genet Med. 2017;19(4):484.

      2. Miller DT, Lee K, Chung WK et al. ACMG SF v3. 0 List for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(8):1381-1390. Published correction appears in Genet Med. 2021;23(8):1582-1584.

        • Faggion Vinholo T.F.
        • Brownstein A.J.
        • Ziganshin B.A.
        • et al.
        Genes associated with thoracic aortic aneurysm and dissection: 2019 update and clinical implications.
        Aorta (Stamford). 2019; 7: 99-107
        • Chou E.L.
        • Lindsay M.E.
        The genetics of aortopathies: hereditary thoracic aortic aneurysms and dissections.
        Am J Med Genet C Semin Med Genet. 2020; 184: 136-148
        • Demo E.
        • Rigelsky C.
        • Rideout A.L.
        • et al.
        Genetics and precision medicine: heritable thoracic aortic disease.
        Med Clin North Am. 2019; 103: 1005-1019
        • Lee C.
        • Elsekaily O.
        • Kochan D.C.
        • et al.
        Penetrance and outcomes at 1-year following return of actionable variants identified by genome sequencing.
        Genet Med. 2021; 23: 1192-1201
        • Gottesman O.
        • Kuivaniemi H.
        • Tromp G.
        • et al.
        The electronic medical records and genomics (eMERGE) network: past, present, and future.
        Genet Med. 2013; 15: 761-771
        • McCarty C.A.
        • Chisholm R.L.
        • Chute C.G.
        • et al.
        The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies.
        BMC Med Genomics. 2011; 4: 13
        • Von Elm E.
        • Altman D.G.
        • Egger M.
        • et al.
        The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.
        Bull World Health Organ. 2007; 85: 867-872
        • eMERGE Clinical Annotation Working Group
        Frequency of genomic incidental findings among 21,915 eMERGE network participants.
        Genet Med. 2020; 22: 1470-1477
        • eMERGE Consortium
        Electronic address: [email protected], eMERGE Consortium. Harmonizing clinical sequencing and interpretation for the eMERGE III network.
        Am J Hum Genet. 2019; 105: 588-605
        • Fossey R.
        • Kochan D.
        • Winkler E.
        • et al.
        Ethical considerations related to return of results from genomic medicine projects: the eMERGE network (phase III) experience.
        J Pers Med. 2018; 8: 2
        • Wiesner G.L.
        • Kulchak Rahm A.
        • Appelbaum P.
        • et al.
        Returning results in the genomic era: initial experiences of the eMERGE Network.
        J Pers Med. 2020; 10: 30
      3. Green RC, Berg JS, Grody WW et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15(7):565-574. Published correction appears in Genet Med. 2017;19(5):606.

        • Kullo I.J.
        • Olson J.
        • Fan X.
        • et al.
        The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic genomic medicine implementation study: design and initial results.
        Mayo Clin Proc. 2018; 93: 1600-1610
        • Harris P.A.
        • Taylor R.
        • Thielke R.
        • Payne J.
        • Gonzalez N.
        • Conde J.G.
        Research Electronic Data Capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support.
        J Biomed Inform. 2009; 42: 377-381
        • Devereux R.B.
        • de Simone G.
        • Arnett D.K.
        • et al.
        Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons≥ 15 years of age.
        Am J Cardiol. 2012; 110: 1189-1194
        • Williams M.S.
        Early lessons from the implementation of genomic medicine programs.
        Annu Rev Genomics Hum Genet. 2019; 20: 389-411
        • Peterson J.F.
        • Roden D.M.
        • Orlando L.A.
        • Ramirez A.H.
        • Mensah G.A.
        • Williams M.S.
        Building evidence and measuring clinical outcomes for genomic medicine.
        Lancet. 2019; 394: 604-610
        • Wenger B.M.
        • Patel N.
        • Lui M.
        • et al.
        A genotype-first approach to exploring Mendelian cardiovascular traits with clear external manifestations.
        Genet Med. 2021; 23: 94-102
        • Ostberg N.P.
        • Zafar M.A.
        • Ziganshin B.A.
        • Elefteriades J.A.
        The genetics of thoracic aortic aneurysms and dissection: a clinical perspective.
        Biomolecules. 2020; 10: 182
        • Haer-Wigman L.
        • van der Schoot V.
        • Feenstra I.
        • et al.
        1 in 38 individuals at risk of a dominant medically actionable disease.
        Eur J Hum Genet. 2019; 27: 325-330
        • Natarajan P.
        • Gold N.B.
        • Bick A.G.
        • et al.
        Aggregate penetrance of genomic variants for actionable disorders in European and African Americans.
        Sci Transl Med. 2016; 8 (:364ra151-364ra151.
      4. Dietz H. FBN1-related Marfan syndrome. GeneReviews [internet]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, eds. University of Washington; Updated February 17, 2022. Accessed February 17, 2022.

      5. Loeys BL, Dietz HC. Loeys-Dietz syndrome. GeneReviews [internet]. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. University of Washington; Updated March 1, 2018. Accessed March 1, 2018.

        • Loeys B.L.
        • Schwarze U.
        • Holm T.
        • et al.
        Aneurysm syndromes caused by mutations in the TGF-β receptor.
        N Engl J Med. 2006; 355: 788-798
        • Isselbacher E.M.
        • Lino Cardenas C.L.
        • Lindsay M.E.
        Hereditary influence in thoracic aortic aneurysm and dissection.
        Circulation. 2016; 133: 2516-2528
        • Faggion Vinholo T.F.
        • Zafar M.A.
        • Ziganshin B.A.
        • Elefteriades J.A.
        Nonsyndromic thoracic aortic aneurysms and dissections-is screening possible?.
        Semin Thorac Cardiovasc Surg. 2019; 31: 628-634
      6. Byers PH. Vascular Ehlers-Danlos syndrome. GeneReviews [internet]. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. University of Washington. Updated February 21, 2019. Accessed February 21, 2019.

        • Takeda N.
        • Komuro I.
        Genetic basis of hereditary thoracic aortic aneurysms and dissections.
        J Cardiol. 2019; 74: 136-143
        • Grosse S.D.
        • Khoury M.J.
        What is the clinical utility of genetic testing?.
        Genet Med. 2006; 8: 448-450
        • McMurry A.J.
        • Murphy S.N.
        • MacFadden D.
        • et al.
        SHRINE: enabling nationally scalable multi-site disease studies.
        PLoS One. 2013; 8e55811
        • Vassy J.L.
        • Christensen K.D.
        • Schonman E.F.
        • et al.
        The impact of whole-genome sequencing on the primary care and outcomes of healthy adult patients: a pilot randomized trial.
        Ann Intern Med. 2017; 167: 159-169
        • Shaibi G.Q.
        • Kullo I.J.
        • Singh D.P.
        • et al.
        Returning genomic results in a Federally Qualified Health Center: the intersection of precision medicine and social determinants of health.
        Genet Med. 2020; 22: 1552-1559